The Alzheimer’s disease (AD) market across the eight major markets (8MM USA, France, Germany, Italy, Spain, UK, Japan, and ...

French biotech company Transgene (Euronext Paris: TNG) has appointed Anne Stehlin as chief quality officer and responsible ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) today authorised Onswik (insulin efsitora alfa) for the ...

The Russian government plans to significantly reduce public procurements of cancer drugs in 2027, that will be mainly due to ...

Italy's Sibylla Biotech, an oncology firm developing small-molecule protein degraders that interfere with protein folding, ...

Telix Pharmaceuticals (ASX: TLX) began US commercial supply of Pixclara (floretyrosine F 18), while Knight Therapeutics (TSX: ...

US clinical-stage biotech Tortugas Neuroscience has announced positive Phase IIb trial results for obuprazine (TRTL-107), the ...

US biotech companies Bambusa Therapeutics and Aspen Neuroscience have filed for initial public offerings (IPOs), seeking ...

Boston, USA-based computational drug discovery company Nimbus Therapeutics has made three senior appointments as it expands ...

The US Food and Drug Administration (FDA) has signaled a clear shift in how it intends to scrutinize clinical trial data ...

Canadian eye health company Bausch + Lomb (NYSE: BLCO) has appointed Thomas Appio interim chief executive following an ...

Governor Josh Shapiro and Department of Community and Economic Development (DCED) Secretary Rick Siger announced the ...